Literature DB >> 11256881

Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features.

P Mercié1, O Garnier, L Lascoste, M Renard, C Closse, F Durrieu, G Marit, R M Boisseau, F Belloc.   

Abstract

OBJECTIVE: Cell death is generally classified into two large categories: apoptosis, which represents active, physiological programmed cell death, and necrosis, which represents passive cell death without underlying regulatory mechanisms. Apoptosis plays an important role in tissue homeostasis and its role in endothelium integrity can be influenced by the functional status of endothelial cells. Homocysteine, a sulfated amino-acid product of methionine demethylation, is an independent risk factor for vascular disease (arterial and venous thombosis). Our goal was to investigate the thiol-derivatives effect on the endothelial cell apoptosis.
METHODS: Three parameters were measured: mitochondrial membrane potential using DiOC6(3) as the probe, DEVDase activation, and phosphatidylserine exposure on the cell surface with fluorosceinated annexin V labeling which allows apoptosis to be distinguished from necrosis.
RESULTS: Homocysteine-thiolactone induced endothelial cell apoptosis in a concentration-dependent manner (range: 50-200 microM), independently of the caspase pathway. Only homocysteine-thiolactone, among the thiol derivatives tested, induced apoptosis. Apoptosis was not influenced by the serum concentration in culture medium, suggesting that the observed apoptotic process could occur in vivo. None of the inhibitors used (e.g., leupeptin, fumosinin B1, catalase, or z-VAD-fmk) was able to prevent homocysteine-induced apoptosis of vascular endothelial cells.
CONCLUSION: The apoptosis of vascular endothelial cells induced by high concentration of homocysteine-thiolactone might be one step atherosclerotic cardiovascular disease, and contribute to its complication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11256881     DOI: 10.1023/a:1009652011466

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  15 in total

1.  Capillary electrophoretic screening for the inhibition of homocysteine thiolactone-induced protein oligomerization.

Authors:  Arther T Gates; Mark Lowry; Kristin A Fletcher; Abitha Murugeshu; Oleksandr Rusin; James W Robinson; Robert M Strongin; Isiah M Warner
Journal:  Anal Chem       Date:  2007-09-29       Impact factor: 6.986

2.  Association between low red blood cell 5-methyltetrahydrofolate and hyperhomocysteinaemia with hypertension : a cross-sectional study.

Authors:  Jamal Golbahar; Esmael Mostafavi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-02-19

3.  Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

Authors:  Shima Jalili; Reza Yousefi; Mohammad-Mehdi Papari; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

4.  Hyperhomocysteinemia regulated SCF expression in cultured cardiomyocytes via modulation of NF-κB activities.

Authors:  Xia Zhao; Dong Kuang; Yuping Duan; Guixiang Xiao; Juan Ni; Yaqi Duan; Guoping Wang
Journal:  Mol Cell Biochem       Date:  2015-04-21       Impact factor: 3.396

5.  Homocysteine and nitric oxide levels in plasma of patients with pseudoexfoliation syndrome, pseudoexfoliation glaucoma, and primary open-angle glaucoma.

Authors:  Ozgül Altintaş; Hale Maral; Nurşen Yüksel; V Levent Karabaş; Meltem O Dillioğlugil; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

6.  Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone.

Authors:  Mohsen Kerkeni; Mehdi Tnani; Laurence Chuniaud; Abdelhedi Miled; Khira Maaroufi; François Trivin
Journal:  Mol Cell Biochem       Date:  2006-05-19       Impact factor: 3.396

7.  Mechanistic investigation of N-homocysteinylation-mediated protein-gold nanoconjugate assembly.

Authors:  Arther T Gates; Leonard Moore; Monica R Sylvain; Christina M Jones; Mark Lowry; Bilal El-Zahab; James W Robinson; Robert M Strongin; Isiah M Warner
Journal:  Langmuir       Date:  2009-08-18       Impact factor: 3.882

8.  Plasma and aqueous humour levels of homocysteine in exfoliation syndrome.

Authors:  Tuomo Puustjärvi; Hillevi Blomster; Matti Kontkanen; Kari Punnonen; Markku Teräsvirta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

9.  Gold nanoparticle sensor for homocysteine thiolactone-induced protein modification.

Authors:  Arther T Gates; Sayo O Fakayode; Mark Lowry; Gabriela M Ganea; Abitha Murugeshu; James W Robinson; Robert M Strongin; Isiah M Warner
Journal:  Langmuir       Date:  2008-03-07       Impact factor: 3.882

10.  Homocysteine-Thiolactone Modulates Gating of Mitochondrial Voltage-Dependent Anion Channel (VDAC) and Protects It from Induced Oxidative Stress.

Authors:  T Daniel Tuikhang Koren; Subhendu Ghosh
Journal:  J Membr Biol       Date:  2022-02-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.